New-Onset Anasarca in a Previously Healthy 10-year-old.

[1]  S. Wittekind,et al.  Contemporary Outcomes of Pediatric Restrictive Cardiomyopathy: A Single-Center Experience , 2018, Pediatric Cardiology.

[2]  S. Ware,et al.  Novel pathogenic variants in filamin C identified in pediatric restrictive cardiomyopathy , 2018, Human mutation.

[3]  Mario J. Garcia.  Constrictive Pericarditis Versus Restrictive Cardiomyopathy? , 2016, Journal of the American College of Cardiology.

[4]  J. Carlin,et al.  Sudden death in childhood cardiomyopathy: results from a long-term national population-based study. , 2015, Journal of the American College of Cardiology.

[5]  B. Varan,et al.  Use of oral budesonide in the management of protein-losing enteropathy due to restrictive cardiomyopathy , 2013, Cardiology in the Young.

[6]  K. Nasir,et al.  Outcomes of adults with restrictive cardiomyopathy after heart transplantation. , 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[7]  S. Colan,et al.  Outcomes of Restrictive Cardiomyopathy in Childhood and the Influence of Phenotype: A Report From the Pediatric Cardiomyopathy Registry , 2012, Circulation.

[8]  S. Webber,et al.  Restrictive cardiomyopathy in childhood. , 2010, Heart failure clinics.

[9]  D. Arab,et al.  The efficacy of brain natriuretic peptide levels in differentiating constrictive pericarditis from restrictive cardiomyopathy. , 2005, Journal of the American College of Cardiology.

[10]  M. Fishbein,et al.  Idiopathic restrictive cardiomyopathy. , 1984, Circulation.

[11]  V. Moiseev,et al.  Restrictive cardiomyopathy. , 1997, The New England journal of medicine.